Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients

NCT06778538 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma (ccRCC)

Interventions

DIAGNOSTIC_TEST: Immunohistochemistry; WB; PCR

Sponsor

Shang Panfeng

Collaborators

[object Object]